All terms in GO
| Label | Id | Description |
|---|---|---|
| glial cell-derived neurotrophic factor receptor binding | GO_0030116 | [A growth factor that binds selectively and non-covalently to glial cell-derived neurotrophic factor receptors.] |
| membrane coat | GO_0030117 | [Any of several different proteinaceous coats that can associate with membranes. Membrane coats include those formed by clathrin plus an adaptor complex, the COPI and COPII complexes, and possibly others. They are found associated with membranes on many vesicles as well as other membrane features such as pits and perhaps tubules.] |
| membrane protein complex | GO_0098796 | [Any protein complex that is part of a membrane.] |
| coated membrane | GO_0048475 | [A single or double lipid bilayer with any of several different proteinaceous coats that can associate with membranes. Membrane coats include those formed by clathrin plus an adaptor complex, the COPI and COPII complexes.] |
| clathrin coat | GO_0030118 | [A membrane coat found on coated pits and some coated vesicles; consists of polymerized clathrin triskelions, each comprising three clathrin heavy chains and three clathrin light chains, linked to the membrane via one of the AP adaptor complexes.] |
| AP-type membrane coat adaptor complex | GO_0030119 | [Any of several heterotetrameric complexes that link clathrin (or another coat-forming molecule, as hypothesized for AP-3 and AP-4) to a membrane surface; they are found on coated pits and coated vesicles, and mediate sorting of cargo proteins into vesicles. Each AP complex contains two large (a beta and one of either an alpha, gamma, delta, or epsilon) subunits (110-130 kDa), a medium (mu) subunit (approximately 50 kDa), and a small (sigma) subunit (15-20 kDa).] |
| platelet-derived growth factor receptor binding | GO_0005161 | [Interacting selectively and non-covalently with the platelet-derived growth factor receptor.] |
| GO_0005162 | GO_0005162 | |
| nerve growth factor receptor binding | GO_0005163 | [Interacting selectively and non-covalently with the nerve growth factor receptor.] |
| neurotrophin receptor binding | GO_0005165 | [Interacting selectively and non-covalently with a neurotrophin receptor.] |
| tumor necrosis factor receptor binding | GO_0005164 | [Interacting selectively and non-covalently with the tumor necrosis factor receptor.] |
| regulation of endocytosis | GO_0030100 | [Any process that modulates the frequency, rate or extent of endocytosis.] |
| regulation of cellular component organization | GO_0051128 | [Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell structures, including the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.] |
| regulation of vesicle-mediated transport | GO_0060627 | [Any process that modulates the rate, frequency, or extent of vesicle-mediated transport, the directed movement of substances, either within a vesicle or in the vesicle membrane, into, out of or within a cell.] |
| endocytosis | GO_0006897 | [A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle.] |
| neurotrophin p75 receptor binding | GO_0005166 | [Interacting selectively and non-covalently with the neurotrophin p75 receptor.] |
| natural killer cell activation | GO_0030101 | [The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.] |
| lymphocyte activation | GO_0046649 | [A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor.] |
| neurotrophin TRK receptor binding | GO_0005167 | [Interacting selectively and non-covalently with a neurotrophin TRK receptor.] |
| neurotrophin TRKA receptor binding | GO_0005168 | [Interacting selectively and non-covalently with the neurotrophin TRKA receptor.] |